Can You Trust Your Gut? Implicating a Disrupted Intestinal Microbiome in the Progression of NAFLD/NASH.

Frontiers in Endocrinology
Kavita Jadhav, Taylor S Cohen

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disorders, ranging from fatty liver to a more insulin resistant, inflammatory and fibrotic state collectively termed non-alcoholic steatohepatitis (NASH). In the United States, 30%-40% of the adult population has fatty liver and 3%-12% has NASH, making it a major public health concern. Consumption of diets high in fat, obesity and Type II diabetes (T2D) are well-established risk factors; however, there is a growing body of literature suggesting a role for the gut microbiome in the development and progression of NAFLD. The gut microbiota is separated from the body by a monolayer of intestinal epithelial cells (IECs) that line the small intestine and colon. The IEC layer is exposed to luminal contents, participates in selective uptake of nutrients and acts as a barrier to passive paracellular permeability of luminal contents through the expression of tight junctions (TJs) between adjacent IECs. A dysbiotic gut microbiome also leads to decreased gut barrier function by disrupting TJs and the gut vascular barrier (GVB), thus exposing the liver to microbial endotoxins. These endotoxins activate hepatic Toll-like receptors (TLRs), further promoting the progression of fatty li...Continue Reading

References

Jul 1, 1990·The Journal of Nutrition·P M Nishina, R A Freedland
Sep 1, 1986·The Journal of Nutrition·T Høverstad, T Midtvedt
Jul 10, 1981·Nucleic Acids Research·S Anderson
Feb 27, 1998·Frontiers in Bioscience : a Journal and Virtual Library·J Y Chiang
Aug 24, 2000·Journal of Medicinal Chemistry·P R MaloneyT M Willson
Nov 8, 2002·The Journal of Biological Chemistry·Gilles LambertChristopher J Sinal
Mar 29, 2003·Physiological Reviews·Michael Trauner, James L Boyer
Apr 30, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yong-Han PaikDavid A Brenner
Nov 11, 2003·The Journal of Nutrition·Kirsten L ZambellSharon E Fleming
May 18, 2004·The Journal of Clinical Investigation·Mitsuhiro WatanabeJohan Auwerx
Oct 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Fredrik BäckhedJeffrey I Gordon
Dec 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yuan ZhaiJerzy W Kupiec-Weglinski
Nov 22, 2005·Journal of Lipid Research·Jason M RidlonPhillip B Hylemon
Dec 24, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Xiaokun DingFrank A Anania
Oct 24, 2007·Nature Medicine·Ekihiro SekiRobert F Schwabe
Dec 18, 2007·Applied and Environmental Microbiology·Muriel DerrienWillem M de Vos
Oct 8, 2008·Nucleic Acids Research·Brandi L CantarelBernard Henrissat
Oct 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Buck S SamuelJeffrey I Gordon
Dec 20, 2008·The Journal of Biological Chemistry·Sohini MukherjeeLora V Hooper
Feb 27, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Don C RockeyUNKNOWN American Association for the Study of Liver Diseases
Mar 18, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Luca MieleAntonio Grieco
Jun 30, 2009·The Journal of Allergy and Clinical Immunology·Katherine R Groschwitz, Simon P Hogan
Jul 29, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Astrid SprussIna Bergheim
Oct 21, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ryan W Himes, C Wayne Smith
Oct 27, 2009·Nature Reviews. Immunology·Jerrold R Turner
Mar 6, 2010·Science·Matam Vijay-KumarAndrew T Gewirtz
May 12, 2010·Cold Spring Harbor Perspectives in Biology·Toby Lawrence
Aug 21, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Sylvie RabotChieh J Chou
Aug 21, 2010·Inflammatory Bowel Diseases·Sa'ad Y Salim, Johan D Söderholm
Mar 31, 2011·European Journal of Gastroenterology & Hepatology·Srinivasan DasarathySatish C Kalhan
Feb 3, 2012·Nature·Jorge Henao-MejiaRichard A Flavell
May 11, 2012·Gut Microbes·Harry J FlintEvelyne Forano
Jun 5, 2012·The Journal of Biological Chemistry·Holly A CyphertF Bradley Hillgartner
Sep 19, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kouichi MiuraEkihiro Seki
Oct 12, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lixin ZhuSteven R Gill
Oct 24, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Jane M M Natividad, Elena F Verdu

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
IECs

Clinical Trials Mentioned

NCT02469272

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.